V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10004105 | 10002595 | 1.71 | 64.5 | Adjuvant (A) | 2014-02-04 | 2014-02-26 | IMATINIB | N | Y | 10508069 | CVD |
| 10004106 | 10002596 | 1.78 | 0 | Palliative (P) | 2017-08-23 | 2017-08-23 | CTD Attenuated (Thalidomide 50mg) | N | N | 10508084 | FLUOROURACIL + MITOMYCIN + RT |
| 10004107 | 10002597 | 1.78 | 0 | Adjuvant (A) | 2018-04-07 | 2018-04-08 | EC | 2 | N | 10508147 | IMATINIB |
| 10004108 | 10002598 | 1.73 | 88.7 | Adjuvant (A) | 2016-11-07 | 2017-09-21 | Gemcitabine + Capecitabine | N | N | 10508256 | TEMOZOLOMIDE + RT |
| 10004109 | 10002599 | 1.71 | 62.3 | Disease modification (D) | 2017-07-13 | 2017-07-15 | Azacitidine | 02 | N | 10508264 | AZACITIDINE |
| 10004110 | 10002599 | 1.81 | 67.7 | Palliative (P) | 2018-06-05 | 2018-06-12 | Fluorouracil + Folinic Acid Weekly | 2 | N | 10508264 | FLUOROURACIL |
| 10004111 | 10002600 | 1.76 | null | Curative (C) | 2015-08-05 | 2015-08-06 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 10508395 | CISPLATIN + RT |
| 10004112 | 10002601 | 1.52 | 61.4 | Palliative (P) | 2018-08-18 | 2018-08-28 | Fluorouracil + Folinic Acid Weekly | 02 | N | 10508420 | FLUOROURACIL |
| 10004113 | 10002602 | 1.6 | 55 | Disease modification (D) | 2017-03-20 | 2017-03-29 | Cisplatin | 02 | Y | 10508428 | AZACITIDINE |
| 10004114 | 10006579 | 1.72 | 96.2 | Curative (C) | 2017-09-16 | 2017-09-18 | Bortezomib +/- Dexamethasone | N | N | 10508447 | CTD |
| 10004115 | 10006579 | 1.66 | 74.25 | Palliative (P) | null | 2018-11-13 | Irinotecan + Modified De Gramont | 2 | null | 10508447 | IRINOTECAN + MDG |
| 10004116 | 10002603 | 1.68 | 55.6 | Palliative (P) | 2013-02-10 | 2013-03-17 | IMATINIB | 02 | Y | 10508478 | CHOP |
| 10004117 | 10002603 | 1.73 | 93.7 | Palliative (P) | 2018-03-10 | 2018-03-18 | Temozolomide + RT | N | N | 10508478 | TEMOZOLOMIDE + RT |
| 10004118 | 10002603 | null | null | null | null | 2017-12-20 | CAPECITABINE + RT | null | null | 10508478 | CAPECITABINE + RT |
| 10004119 | 10002604 | 1.89 | 77.3 | Palliative (P) | 2016-07-31 | 2016-08-08 | Chlorambucil | 02 | N | 10508669 | EC |
| 10004120 | 10002604 | 1.65 | 65.8 | Adjuvant (A) | 2018-07-14 | 2018-07-25 | Fluorouracil+Mitomycin+RT (Bladder) | N | Y | 10508669 | CISPLATIN + ETOPOSIDE |
| 10004121 | 10002604 | 1.75 | 75 | Curative (C) | 2015-09-22 | 2015-10-10 | Chlorambucil | N | Y | 10508669 | CAPECITABINE + CISPLATIN |
| 10004122 | 10002605 | 1.7 | 82.8 | Curative (C) | 2018-03-28 | 2018-04-07 | BCG Intravesical | 02 | N | 10508726 | PACLITAXEL |
| 10004123 | 10002606 | null | 65.2 | Palliative (P) | 2017-04-21 | 2017-05-02 | Paclitaxel 7 day | 02 | N | 10508761 | FLUOROURACIL + MITOMYCIN + RT |
| 10004124 | 10002607 | 1.66 | 61 | Adjuvant (A) | 2016-04-03 | 2016-04-12 | Fluorouracil + Folinic Acid Weekly | 02 | N | 10508782 | FLUOROURACIL |
| 10004125 | 10006582 | 1.77 | 63 | Adjuvant (A) | 2018-05-26 | 2018-06-23 | FLUOROURACIL | 02 | null | 10508829 | FLUOROURACIL |
| 10004126 | 10006582 | null | 83.1 | Adjuvant (A) | 2016-10-25 | 2016-10-25 | IMATINIB | null | N | 10508829 | IMATINIB |
| 10004127 | 10006582 | 1.59 | null | Palliative (P) | 2016-03-01 | 2016-03-01 | BCG Intravesical | N | N | 10508829 | CISPLATIN + ETOPOSIDE |
| 10004128 | 10002608 | 1.64 | 55.6 | Curative (C) | 2015-07-05 | 2015-07-20 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 10508910 | CISPLATIN + RT |
| 10004129 | 10002609 | 1.91 | 76.8 | Adjuvant (A) | 2018-09-05 | 2018-09-26 | FEC + DOCETAXEL | N | N | 10508927 | FEC + DOCETAXEL |
| 10004130 | 10002609 | 1.7 | 53.4 | null | 2017-06-21 | 2017-07-04 | BCG Intravesical | 02 | N | 10508927 | PACLITAXEL |
| 10004131 | 10002610 | 0 | 82.7 | Neo-adjuvant (N) | 2018-11-21 | 2018-11-24 | Bortezomib +/- Dexamethasone | 02 | null | 10508982 | ABVD |
| 10004132 | 10002611 | 1.7 | 84 | Palliative (P) | 2018-02-15 | 2018-03-04 | ABVD | N | N | 10509037 | CAPECITABINE + CISPLATIN |
| 10004133 | 10006584 | 1.6 | 63.1 | Neo-adjuvant (N) | 2016-10-02 | 2016-10-23 | ABVD | 2 | Y | 10509039 | AZACITIDINE |
| 10004134 | 10006584 | 1.62 | 76 | Curative (C) | 2017-03-22 | 2017-03-22 | BCG Intravesical | 2 | N | 10509039 | FLUOROURACIL + MITOMYCIN + RT |
| 10004135 | 10006584 | 1.67 | 60.7 | Disease modification (D) | 2016-04-29 | 2016-05-06 | Cisplatin 7 day | 02 | N | 10509039 | IMATINIB |
| 10004136 | 10002612 | 1.51 | null | Neo-adjuvant (N) | null | 2014-07-07 | MaxiCHOP (Cycle 1) | N | N | 10509197 | CTD |
| 10004137 | 10002613 | 1.71 | 75.9 | Disease modification (D) | 2016-09-12 | 2016-09-14 | CTD | N | N | 10509248 | CHOP |
| 10004138 | 10002614 | 1.89 | 67.4 | Neo-adjuvant (N) | 2014-12-26 | 2015-01-15 | CAPECITABINE + RT | N | Y | 10509263 | CAPECITABINE + RT |
| 10004139 | 10002614 | 1.8 | 56 | Adjuvant (A) | 2018-08-08 | 2018-08-15 | Fluorouracil + Folinic Acid Weekly | 2 | N | 10509263 | FLUOROURACIL |
| 10004140 | 10008163 | 1.74 | 61.6 | Adjuvant (A) | null | 2014-12-07 | BCG Intravesical | 2 | null | 10509302 | BORTEZOMIB |
| 10004141 | 10002615 | 1.58 | 58.1 | Palliative (P) | 2017-08-01 | 2017-08-15 | ABVD | 02 | N | 10509305 | BCG |
| 10004142 | 10002616 | null | 83.5 | Adjuvant (A) | 2018-03-29 | 2018-03-29 | FEC + DOCETAXEL | N | N | 10509356 | FEC + DOCETAXEL |
| 10004143 | 10002617 | 1.8 | 48 | Palliative (P) | 2018-06-29 | 2018-07-02 | FLUOROURACIL + IRINOTECAN | N | N | 10509471 | IRINOTECAN + MDG |
| 10004144 | 10002618 | 1.54 | 117 | null | 2018-12-11 | 2018-12-26 | CTD | 02 | N | 10509507 | CTD |
| 10004145 | 10002619 | null | 90.1 | Curative (C) | 2015-12-04 | 2015-12-19 | EC | N | N | 10509678 | EC |
| 10004146 | 10002620 | 1.75 | 80.8 | Disease modification (D) | 2018-08-10 | 2018-09-01 | EC | 02 | N | 10509704 | FLUOROURACIL + MITOMYCIN + RT |
| 10004147 | 10002620 | 1.71 | 99.8 | Palliative (P) | 2015-10-17 | 2015-10-18 | Bortezomib + Cyclophos + Dex | N | N | 10509704 | CTD |
| 10004148 | 10002620 | null | 74.6 | Adjuvant (A) | 2016-11-30 | 2016-12-02 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 10509704 | PACLITAXEL |
| 10004149 | 10002621 | 1.5 | 55.6 | null | 2017-07-19 | 2017-08-02 | Azacitidine | 2 | N | 10509794 | AZACITIDINE |
| 10004150 | 10002622 | 1.57 | 71.7 | Adjuvant (A) | 2018-08-14 | 2018-08-28 | Capecitabine + Cisplatin | N | N | 10509830 | TEMOZOLOMIDE + RT |
| 10004151 | 10002623 | null | 80.8 | Disease modification (D) | 2016-02-02 | 2016-02-16 | Cisplatin 7 day | 2 | Y | 10509834 | CISPLATIN |
| 10004152 | 10002623 | 1.54 | 78.9 | Adjuvant (A) | 2018-01-05 | 2018-01-22 | CYCLOPHOSPHAMIDE + EPIRUBICIN | N | N | 10509834 | ABIRATERONE |
| 10004153 | 10002624 | 1.71 | 0 | Palliative (P) | 2018-04-05 | 2018-04-14 | Bortezomib +/- Dexamethasone | 2 | N | 10509847 | BORTEZOMIB |
| 10004154 | 10002625 | null | 76.5 | null | 2016-07-02 | 2016-07-02 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10509855 | CTD |